Area of research
Pulmonary and Respiratory Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Occupational and environmental lung diseases, Pleural and Pulmonary Diseases, Medical Imaging and Pathology Studies, and Corneal Surgery and Treatments.
Steroid refractory desquamative interstitial pneumonia responsive to intravenous cyclophosphamide.
Factors predictive of progression in lesions categorised as well-differentiated papillary mesothelial tumour of the pleura, tunica vaginalis and peritoneum: a scoping review.
Validation of chemoresistance phenotypes in pleural mesothelioma across 2D, 3D, and in vivo models.
A High-Fidelity Patient-Derived Organoid Platform Recapitulates the Dynamic Metabolic Landscape of Cisplatin Tolerance in Mesothelioma
Mesothelioma Incidence Rates in Australia since 1982: Exploring Age, Period, and Cohort Effects and Future Projections
A combination of PD-1 and TIGIT immune checkpoint inhibitors elicits a strong anti-tumour response in mesothelioma.
Acute urinary tract infection elicits bladder afferent hypersensitivity.
Mesothelioma Incidence Rates in Australia since 1982: Exploring Age, Period, and Cohort Effects and Future Projections.
Molecular testing of lung cancer in Australia: consensus best practice recommendations from the Royal College of Pathologists of Australasia in collaboration with the Thoracic Oncology Group of Australasia.
A histomorphological atlas of resected mesothelioma discovered by self-supervised learning from 3446 whole-slide images.
Microvascular density using the Chalkley method: a potential alternative to the World Health Organization nuclear grading in pleural mesothelioma prognostication.
Publisher Correction to: Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer.
An Evaluation Into the Robustness of Grading of Pleural Mesothelioma Outside of Specialist Centres.
Guidelines for Pathologic Diagnosis of Mesothelioma: 2023 Update of the Consensus Statement From the International Mesothelioma Interest Group
Guidelines for Pathologic Diagnosis of Mesothelioma: 2023 Update of the Consensus Statement From the International Mesothelioma Interest Group.
Establishing mesothelioma patient-derived organoid models from malignant pleural effusions.
Proteomic profiling of paired human liver homogenate and tissue derived extracellular vesicles.
Mesothelioma in the pleura, pericardium and peritoneum: Recommendations from the International Collaboration on Cancer Reporting (ICCR).
Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers.
Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer.
Health Effects of Occupational and Environmental Exposures to Nuclear Power Plants: A Meta-Analysis and Meta-Regression.
Lung cancer caused by asbestos: What a reporting pathologist needs to know.
An unusual cause of progressive dyspnoea, pulmonary nodules and pleural effusions.
The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature.
Nonmesothelial Spindle Cell Tumors of Pleura and Pericardium.
Incidence and mortality from malignant mesothelioma 1982-2020 and relationship with asbestos exposure: the Australian Mesothelioma Registry.
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer.
Pitfalls in Cutaneous Melanoma Diagnosis and the Need for New Reliable Markers.
Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1.